Proteomics Intl Labs Ltd has released a press release.
Appendix 4C - June 2018 Quarterly Report
Filed with ASX ·
6ix hasn’t read this filing yet.
Proteomics International Laboratories Ltd. on 6ix
Story so far
Earlier from Proteomics International Laboratories
- Proteomics secures major contract - nears cash flow positive
- Further information on new licence deals in USA and Mexico
- Proteomics signs deal with Patia for PromarkerD in Mexico
- Proteomics signs deal to launch PromarkerD test in US market
- Appendix 4C - March 2018 Quarterly Report
Later from Proteomics International Laboratories
- Diagnostics update- Pipeline yields potential new biomarkers
- Proteomics to receive $928k from sale of shareholding in CPR
- Proteomics & Atturos partner to target diagnostics in Europe
- Proteomics receives $834k in R&D Tax Incentive
- Diabetic kidney disease test enters Europe & Export Award
Follow Proteomics International Laboratories into a list and get an email when it puts out news.
Follow Proteomics International Laboratories